![](/img/cover-not-exists.png)
A phase 1 and dose-finding study of LY2523355 (litronesib), an Eg5 inhibitor, in Japanese patients with advanced solid tumors
Wakui, Hiroshi, Yamamoto, Noboru, Kitazono, Satoru, Mizugaki, Hidenori, Nakamichi, Shinji, Fujiwara, Yutaka, Nokihara, Hiroshi, Yamada, Yasuhide, Suzuki, Kohei, Kanda, Hironori, Akinaga, Shiro, TamuraVolume:
74
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-014-2467-z
Date:
July, 2014
File:
PDF, 366 KB
english, 2014